Clene (FRA:84C0) FFO


FRA:84C0 Clene Inc FRA:84C0
33 GF Score
Price €4.90
GF Value €0.72
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clene FFO?

FFO (Funds from operations) only applies to REITs.

FRA:84C0
33GF Score
Clene Inc FRA:84C0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (FRA:84C0) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of €4.90 is trading 580.6% above its estimated GF Value™ of €0.72. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for FRA:84C0:

  • FFO:
  • GF Value™: €0.72 vs. price of €4.90 (580.6% above fair value)
  • GF Score™: 33/100 with 9 warning signs

No single metric tells the full story. See the FRA:84C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clene Business Description

Other Exchanges CLNN:USA
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
33GF Score

Get the complete analysis for FRA:84C0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.90
Price
€0.72
GF Value